This study demonstrated that high CD44 expression is associated with metastasis to lymph nodes and distant metastasis, poorer survival of the patients, tumor recurrence, higher tumor stage and grade and aggressive clinicopathological features. This evidence concerns the gene CD44 and neoplasm.